Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies
Bo Zhao, Xinrong Hu, Weidong Wang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 1
Kidney-tonifying blood-activating decoction delays ventricular remodeling in rats with chronic heart failure by regulating gut microbiota and metabolites and p38 mitogen-activated protein kinase/p65 nuclear factor kappa-B/aquaporin-4 signaling pathway
Rui‐Hua Xu, Yanping Bi, Xiaoteng He, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118110-118110
Closed Access | Times Cited: 5
Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis
Jae Woong Jang, Emma Capaldi, Tracy L. Smith, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 5
Gut microbiota-derived metabolites: Potential targets for cardiorenal syndrome
Yu-Chen Lai, Yujie Zhu, Xihui Zhang, et al.
Pharmacological Research (2025), pp. 107672-107672
Open Access
Microbiota‐related metabolites fueling the understanding of ischemic heart disease
Yong Fan, Jiajun Ying, Hongchuang Ma, et al.
iMeta (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 12
The Impact of Trimethylamine N-Oxide and Coronary Microcirculatory Dysfunction on Outcomes following ST-Elevation Myocardial Infarction
Ali Aldujeli, Riddhi Patel, Ingrida Grabauskytė, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 5, pp. 197-197
Open Access | Times Cited: 12
Gut Microbiome and Its Role in Valvular Heart Disease: Not a “Gutted” Relationship
G. Nayak, Kyriakos Dimitriadis, Nikolaos Pyrpyris, et al.
Life (2024) Vol. 14, Iss. 4, pp. 527-527
Open Access | Times Cited: 4
Role of Trimethylamine N-Oxide in Heart Failure
Lele Jing, Honghong Zhang, Qiannan Xiang, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 7
Open Access | Times Cited: 4
Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats
Klaudia Maksymiuk, Mateusz Szudzik, Marta Gawryś-Kopczyńska, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 21
Gut Microbiota and Coronary Artery Disease: Current Therapeutic Perspectives
Themistoklis Katsimichas, Panagiotis Theofilis, Konstantinos Tsioufis, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 256-256
Open Access | Times Cited: 11
Gut microbiota and myocardial fibrosis
Xu Han, Fan Yang, Zhijun Bao
European Journal of Pharmacology (2022) Vol. 940, pp. 175355-175355
Closed Access | Times Cited: 17
Clusterin regulates TRPM2 to protect against myocardial injury induced by acute myocardial infarction injury
Dalei Li, Mengying Wang, Rong Fan, et al.
Tissue and Cell (2023) Vol. 82, pp. 102038-102038
Closed Access | Times Cited: 10
Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms
Siqi Liu, Yufeng He, Yali Zhang, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 10
From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge
Jialun Zhang, Peining Zhu, Siyu Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
The Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease
Honghong Zhang, Lele Jing, Changlin Zhai, et al.
Journal of Cardiovascular Pharmacology (2022)
Open Access | Times Cited: 12
Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: State-of-the-art review
Morris Karmazyn, Xiaohong Tracey Gan
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 11, pp. 2539-2551
Closed Access | Times Cited: 7
Renal fibrosis in type 2 cardiorenal syndrome: An update on mechanisms and therapeutic opportunities
Xia Xu, Bingxuan Zhang, Yajiao Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114901-114901
Open Access | Times Cited: 6
3,3-Dimethyl-1-Butanol and its Metabolite 3,3-Dimethylbutyrate Ameliorate Collagen-induced Arthritis Independent of Choline Trimethylamine Lyase Activity
Sabrina Fechtner, Brendan Allen, Meagan E. Chriswell, et al.
Inflammation (2024)
Open Access | Times Cited: 1
Protective Role of (-)-Epicatechin on Trimethylamine-N-Oxide (TMAO)-Induced Cardiac Hypertrophy via SP1/SIRT1/SUMO1 Signaling Pathway
Siting Hong, Jing Lu, Jiaoyan Li, et al.
Cardiovascular Toxicology (2024) Vol. 24, Iss. 12, pp. 1335-1347
Open Access
3,3-dimethyl-1-butanol and its metabolite 3,3-dimethylbutyrate ameliorate collagen-induced arthritis independent of choline trimethylamine lyase activity
Sabrina Fechtner, Brendan Allen, Meagan E. Chriswell, et al.
Research Square (Research Square) (2023)
Open Access
Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats.
Klaudia Maksymiuk, Mateusz Szudzik, Marta Gawryś - Kopczyńska, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top